Follow
jean-pascal machiels
jean-pascal machiels
Verified email at uclouvain.be
Title
Cited by
Cited by
Year
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
JS De Bono, S Oudard, M Ozguroglu, S Hansen, JP Machiels, I Kocak, ...
The Lancet 376 (9747), 1147-1154, 2010
39832010
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
EEW Cohen, D Souličres, C Le Tourneau, J Dinis, L Licitra, MJ Ahn, ...
The Lancet 393 (10167), 156-167, 2019
13532019
Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial
G Gravis, K Fizazi, F Joly, S Oudard, F Priou, B Esterni, I Latorzeff, ...
The lancet oncology 14 (2), 149-158, 2013
8772013
Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2 …
JPH Machiels, RT Reilly, LA Emens, AM Ercolini, RY Lei, D Weintraub, ...
Cancer research 61 (9), 3689-3697, 2001
5532001
Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
JP Machiels, CR Leemans, W Golusinski, C Grau, L Licitra, V Gregoire
Annals of Oncology 31 (11), 1462-1475, 2020
5252020
Recruitment of latent pools of high-avidity CD8+ T cells to the antitumor immune response
AM Ercolini, BH Ladle, EA Manning, LW Pfannenstiel, TD Armstrong, ...
The Journal of experimental medicine 201 (10), 1591-1602, 2005
4802005
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum …
JPH Machiels, RI Haddad, J Fayette, LF Licitra, M Tahara, JB Vermorken, ...
The Lancet Oncology 16 (5), 583-594, 2015
464*2015
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
T Powles, T Csőszi, M Özgüroğlu, N Matsubara, L Géczi, SYS Cheng, ...
The Lancet Oncology 22 (7), 931-945, 2021
4172021
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
KJ Pienta, JP Machiels, D Schrijvers, B Alekseev, M Shkolnik, SJ Crabb, ...
Investigational new drugs 31, 760-768, 2013
4042013
Trastuzumab for patients with axillary-node–positive breast cancer: results of the FNCLCC-PACS 04 trial
M Spielmann, H Roché, T Delozier, JL Canon, G Romieu, H Bourgeois, ...
Journal of Clinical Oncology 27 (36), 6129-6134, 2009
3702009
Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in …
FE Lecouvet, J El Mouedden, L Collette, E Coche, E Danse, F Jamar, ...
European urology 62 (1), 68-75, 2012
3562012
Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma
TE Hutson, ID Davis, JPH Machiels, PL De Souza, S Rottey, B Hong, ...
Journal of Clinical Oncology 28 (3), 475-480, 2010
3542010
Safety and efficacy of nivolumab monotherapy in recurrent or metastatic cervical, vaginal, or vulvar carcinoma: results from the phase I/II CheckMate 358 trial
RW Naumann, A Hollebecque, T Meyer, MJ Devlin, A Oaknin, J Kerger, ...
Journal of Clinical Oncology 37 (31), 2825, 2019
3462019
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus
G Curigliano, S Banerjee, A Cervantes, MC Garassino, P Garrido, ...
Annals of Oncology 31 (10), 1320-1335, 2020
3112020
HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice
RT Reilly, MBC Gottlieb, AM Ercolini, JPH Machiels, CE Kane, FI Okoye, ...
Cancer research 60 (13), 3569-3576, 2000
3022000
Do intraoperative analgesics influence breast cancer recurrence after mastectomy? A retrospective analysis
P Forget, J Vandenhende, M Berliere, JP Machiels, B Nussbaum, ...
Anesthesia & Analgesia 110 (6), 1630-1635, 2010
2752010
A single‐arm, multicenter, open‐label phase 2 study of lapatinib as the second‐line treatment of patients with locally advanced or metastatic transitional cell carcinoma
C Wülfing, JPH Machiels, DJ Richel, MO Grimm, U Treiber, MR De Groot, ...
Cancer 115 (13), 2881-2890, 2009
2632009
Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of …
JP Machiels, S Subramanian, A Ruzsa, G Repassy, I Lifirenko, A Flygare, ...
The lancet oncology 12 (4), 333-343, 2011
2572011
Comprehensive intrametastatic immune quantification and major impact of immunoscore on survival
B Mlecnik, M Van den Eynde, G Bindea, SE Church, A Vasaturo, ...
JNCI: Journal of the National Cancer Institute 110 (1), 97-108, 2018
2432018
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised …
DP Petrylak, R De Wit, KN Chi, A Drakaki, CN Sternberg, H Nishiyama, ...
The Lancet 390 (10109), 2266-2277, 2017
2422017
The system can't perform the operation now. Try again later.
Articles 1–20